Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • Sponsored Content
    • Affiliate Disclaimer
  • Shop

Anti-diabetic drugs

U.S. Food and Drug Administration
Diabetes / National

FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes

May 17, 2022May 16, 2022 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration says that it recently approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an …

FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes Read More

heart pulse
Cardiology / National

FDA Approves Treatment for Wider Range of Patients with Heart Failure

March 1, 2022February 28, 2022 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration recenlty approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.

FDA Approves Treatment for Wider Range of Patients with Heart Failure Read More

Trending News

  • Jeptha Abbott DAR Kick-off Meeting: Welcoming New Members and Honoring Marian Anderson’s Inspirational Journey

  • HeartWork Organizing Offers Photo Saving Seminars During “Save Your Photos Month”

  • Ladies Who Rock 4 A Cause Music Festival Shines Bright Indoors Amidst Impending Storms

  • The FRIENDS of Chester County Library Fall Book Sale

  • Sen. Muth Announces $10.7 Million in PCCD Funding for SD44 Initiatives

Subscribe for Updates

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

tiffany

Ladies Who Rock 4 A Cause Music Festival Shines Bright Indoors Amidst Impending Storms

September 22, 2023September 21, 2023

Jamie Jimenez-Juarez

Oxford Borough Police Officer Hospitalized After Pursuit of DUI Suspect

September 22, 2023September 22, 2023

Suicide Prevention

Devereux Advanced Behavioral Health Advocates for Suicide Prevention Awareness

September 21, 2023September 21, 2023

Copyright © 2023 MyChesCo.